Published 2 months ago • loading... • Updated 2 months ago

Allergan Aesthetics launches new AA Signature Program at IMCAS 2025 to redefine patient-centric, multimodal treatment plans - PressReach

Summary by pressreach.com

AA Signature provides an innovative approach to treatment planning that focuses on patient outcomes NORTH CHICAGO, Ill., Jan. 29, 2025 /PRNewswire/ — In response to growing demand for personalized, patient-centric aesthetic solutions1,2, Allergan Aesthetics, an AbbVie Company, is proud to unveil the new AA Signature program, an innovative approach to treatment planning harnessing the power of Allergan Aesthetics’ advanced product portfolio to ad…

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

3 Articles

All

Left

Center

Right

dermatologytimes.com

ICYMI: Allergan Unveils AA Signature Program for Personalized Treatment

This innovative approach to multimodal aesthetics care was announced at IMCAS World Congress 2025.

2 months ago

Read Full Article

cosmeticsdesign-europe.com

Galderma, L’Oréal, Unilever & more to present research at IMCAS 2025

The International Master Course on Aging Science (IMCAS) World Congress 2025 will take place from 30 January – 1 February in Paris, where industry experts will share the latest scientific research and technology innovation in dermatology, cosmeceuticals, ageing science, regenerative medicine and plastic surgery.

2 months ago

Read Full Article